Targeting the glucagon receptor family for diabetes and obesity therapy

YM Cho, CE Merchant, TJ Kieffer - Pharmacology & therapeutics, 2012 - Elsevier
Diabetes is a debilitating disease characterized by chronic hyperglycemia and is often
associated with obesity. With diabetes and obesity incidence on the rise, it is imperative to …
被引用次数：180 相关文章

Targeting the glucagon receptor family for diabetes and obesity therapy

YM Cho, CE Merchant… - Pharmacology and …, 2012 - snucm.elsevierpure.com
Diabetes is a debilitating disease characterized by chronic hyperglycemia and is often
associated with obesity. With diabetes and obesity incidence on the rise, it is imperative to …

Targeting the glucagon receptor family for diabetes and obesity therapy

YM Cho, CE Merchant, TJ Kieffer - Pharmacology and Therapeutics, 2012 - infona.pl
Diabetes is a debilitating disease characterized by chronic hyperglycemia and is often
associated with obesity. With diabetes and obesity incidence on the rise, it is imperative to …

Targeting the glucagon receptor family for diabetes and obesity therapy.

YM Cho, CE Merchant, TJ Kieffer - Pharmacology & Therapeutics, 2012 - europepmc.org
Diabetes is a debilitating disease characterized by chronic hyperglycemia and is often
associated with obesity. With diabetes and obesity incidence on the rise, it is imperative to …

Targeting the glucagon receptor family for diabetes and obesity therapy

YM Cho, CE Merchant… - Pharmacology & …, 2012 - pubmed.ncbi.nlm.nih.gov
Diabetes is a debilitating disease characterized by chronic hyperglycemia and is often
associated with obesity. With diabetes and obesity incidence on the rise, it is imperative to …

[引用][C] Targeting the glucagon receptor family for diabetes and obesity therapy

YM Cho, CE Merchant, TJ Kieffer - Pharmacology & Therapeutics, 2012 - cir.nii.ac.jp